EC Neurology

Case Report Volume 15 Issue 4 - 2023

Clinical Monitoring of Sympathetic and Parasympathetic Response with Neurotest during Neurofeedback Therapy in Panic Disorder: A Case Report

Peci Samorindo1, Peci Federica2, Pica Rosjana2 and Castelletti Maddalena3*

1PhD MD, Ce.Ri.Fos, Milan, Italy
2San Celestino Institute, Milan, Italy
3Magenta Medical Center, Milan, Italy

*Corresponding Author: Castelletti Maddalena, Magenta Medical Center, Milan, Italy.
Received: March 02, 2023; Published: March 11, 2023

The purpose of this case report is to highlight the Neurotest as a useful and accessible questionnaire that may be integrated with different and well-established diagnostic and therapeutic tools. The Neurotest is a self-report questionnaire that investigates fluctuations in sympathic, parasympathetic (vagotonic) and GABAergic symptoms. It was administered for 15 weeks to a patient diagnosed with panic disorder. In the same period of time, 15 sessions of Neurofeedback training Alpha/Theta increase were performed with relevant clinical interviews aimed at mentalisation, self-monitoring and sharing of what observed in the progressive Neurotest assessments. Results show the normalization of the scores obtained with the psychometric scales (SCL-90-R, BDI, HAMD, HAMA) and the physiological Alpha and Theta EEG rhythms are restored together with the normotonia assessed by the Neurotest. Monitoring with Neurotest simplified the patient's compliance and sense of self-efficacy, the therapeutic alliance and targeting of treatments.

Keywords: Neurotest; Sympathetic; Parasympathetic; Anxiety Disorders; Neurofeedback; Monitoring

  1. American Psychiatric Association (2013). Manuale diagnostico e statistico dei disturbi mentali – Quinta edizione”. DSM-5. Raffaello Cortina, Milano (2015).
  2. Samorindo Peci., et al. “Neurotest: A New Paradigm for Monitoring Biphasic Trend of Organic Pathologies”. EC Neurology12 (2020): 40-46.
  3. Henderson LP., et al. “Anabolic Androgenic Steroids and Forebrain GABAergic Transmission”. Neuroscience3 (2006): 793-799.
  4. Suyama S and Yada T. “New insight into GABAergic neurons in the hypothalamic feeding regulation”. The Journal of Physiological Sciences6 (2018): 717-722.
  5. Faure A., et al. “Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat”. PLoS One6 (2010): e11223.
  6. Pigott TA. “Anxiety disorders in women”. Psychiatric Clinics of North America3 (2003): 621-672.
  7. Peci S., et al. “The symptomatology of the sympathetic and vagal system as monitoring model of the therapeutic act (Neurotest)”. Abstract, 2016; Poster in XXIV National Congress of the Italian Society of Psychophysiology (2016).
  8. Peci S and Peci F. “Nocebo phenomenon”. Neuropsychological Trends (2016).
  9. Kimmig AS., et al. “Feasibility of NIRS-based neurofeedback training in social anxiety disorder: behavioral and neural correlates”. Journal of Neural Transmission9 (2019): 1175-1185.
  10. Zhao Z., et al. “Real-time functional connectivity-informed neurofeedback of amygdala-frontal pathways reduces anxiety”. Psychotherapy and Psychosomatics 88 (2019): 5-15.
  11. Ahmed SP., et al. “Neurocognitive bases of emotion regulation development in adolescence”. Developmental Cognitive Neuroscience 15 (2015): 11-25.
  12. Kohn N., et al. “Neural network of cognitive emotion regulation – an ALE meta-analysis and MACM analysis”. Neuroimage 87 (2014): 345-355.
  13. Sitaram R., et al. “Closed-loop brain training: the science of neurofeedback”. Nature Reviews Neuroscience 18 (2017): 86-100.
  14. Hamilton M. “Development of a rating scale for primary depressive illness”. British Journal of Clinical Psychology 6 (1967): 278-296.
  15. Reference: Hamilton M. “The assessment of anxiety states by rating”. British Journal of Medical Psychology 32 (1959): 50-55.
  16. Derogatis LR and Savitz KL. “The SCL-90-R, Brief Symptom Inventory, and Matching Clinical Rating Scales”. In M. E. Maruish (Edition.), The use of psychological testing for treatment planning and outcomes assessment Lawrence Erlbaum Associates Publishers (1999): 679-724.
  17. Scillico Pio. “Investigación clínica y práctica terapeutica: un abismo que salvar”. in Revista de psicoterapia 1.4 (1990): 9-32.
  18. Antonella Montano e Giovanni Battista Flebusb. Presentazione del Beck Depression Inventory-Seconda edizione (BDI-II): conferma della struttura bifattoriale in un campione di popolazione italiana”. Psicoterapia Cognitiva e Comportamentale1 (2006): 67-82.
  19. Loeb A., et al. “Expectancy, level of aspiration, performance, and self-evaluation in depression”. American Psychological Association7 (1987): 479.
  20. Giovanni de Girolamo., et al. European Study on the Epidemiology of Mental Disorders-Istituto Superiore di Sanità (2022).

Castelletti Maddalena., et al. “Clinical Monitoring of Sympathetic and Parasympathetic Response with Neurotest during Neurofeedback Therapy in Panic Disorder: A Case Report”. EC Neurology  15.4 (2023): 17-31.